Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6801) 6801
Publication (753) 753
Book Review (119) 119
Book Chapter (73) 73
Magazine Article (34) 34
Newsletter (32) 32
Newspaper Article (16) 16
Book / eBook (10) 10
Conference Proceeding (10) 10
Dissertation (10) 10
Trade Publication Article (6) 6
Reference (3) 3
Web Resource (3) 3
Data Set (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4944) 4944
index medicus (3619) 3619
clostridium difficile (2258) 2258
male (2102) 2102
female (2075) 2075
anti-bacterial agents - therapeutic use (1628) 1628
diarrhea (1603) 1603
infectious diseases (1440) 1440
microbiology (1440) 1440
aged (1376) 1376
middle aged (1350) 1350
antibiotics (1223) 1223
adult (1193) 1193
clostridium infections - drug therapy (1161) 1161
animals (1119) 1119
health aspects (1019) 1019
risk factors (1010) 1010
clostridium difficile - isolation & purification (1006) 1006
disease (990) 990
infection (989) 989
clostridium infections - microbiology (800) 800
epidemiology (797) 797
pharmacology & pharmacy (769) 769
infections (760) 760
enterocolitis, pseudomembranous - drug therapy (756) 756
clostridium difficile - drug effects (754) 754
clostridium-difficile infection (732) 732
gastroenterology & hepatology (701) 701
clostridium-difficile (695) 695
colitis (692) 692
vancomycin (692) 692
treatment outcome (686) 686
aged, 80 and over (676) 676
microbiota (673) 673
bacteria (653) 653
enterocolitis, pseudomembranous - microbiology (627) 627
research (618) 618
feces - microbiology (615) 615
diarrhea - microbiology (577) 577
anti-bacterial agents - pharmacology (567) 567
clostridium infections (565) 565
mortality (561) 561
care and treatment (536) 536
anti-bacterial agents - adverse effects (531) 531
immunology (530) 530
clostridium infections - epidemiology (527) 527
metronidazole (509) 509
risk-factors (506) 506
retrospective studies (503) 503
medicine, general & internal (497) 497
recurrence (497) 497
analysis (475) 475
diagnosis (471) 471
vancomycin - therapeutic use (466) 466
drug therapy (451) 451
adolescent (429) 429
clostridium infections - diagnosis (428) 428
hospitals (414) 414
clostridium difficile - pathogenicity (394) 394
probiotics (388) 388
therapy (386) 386
microbial sensitivity tests (382) 382
metronidazole - therapeutic use (378) 378
prevention (368) 368
pseudomembranous colitis (365) 365
incidence (362) 362
medicine (362) 362
child (361) 361
anti-bacterial agents - administration & dosage (358) 358
inflammatory bowel disease (356) 356
surgery (355) 355
enterocolitis, pseudomembranous - epidemiology (353) 353
diarrhea - drug therapy (342) 342
risk (340) 340
cross infection - microbiology (335) 335
enterocolitis, pseudomembranous - diagnosis (335) 335
clostridium difficile infection (331) 331
internal medicine (328) 328
young adult (327) 327
abridged index medicus (324) 324
fecal microbiota transplantation (316) 316
article (315) 315
cross infection - epidemiology (308) 308
research article (308) 308
clostridium difficile - genetics (307) 307
antibiotic-associated diarrhea (304) 304
mice (303) 303
drug resistance, bacterial (298) 298
medicine & public health (298) 298
clostridium (294) 294
clostridium infections - therapy (285) 285
nosocomial infections (284) 284
transplantation (278) 278
toxin (274) 274
management (269) 269
prevalence (269) 269
patients (265) 265
double-blind (263) 263
inflammatory-bowel-disease (261) 261
usage (260) 260
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6630) 6630
German (81) 81
French (54) 54
Spanish (45) 45
Russian (29) 29
Japanese (21) 21
Polish (17) 17
Czech (13) 13
Italian (11) 11
Danish (10) 10
Korean (10) 10
Dutch (6) 6
Hungarian (6) 6
Romanian (4) 4
Serbian (4) 4
Chinese (3) 3
Hebrew (3) 3
Norwegian (3) 3
Portuguese (2) 2
Arabic (1) 1
Bulgarian (1) 1
Finnish (1) 1
Icelandic (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Interventions to improve antibiotic prescribing practices for hospital inpatients
by Davey, Peter and Marwick, Charis A and Scott, Claire L and Charani, Esmita and Mcneil, Kirsty and Brown, Erwin and Gould, Ian M and Ramsay, Craig R and Michie, Susan
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 02/2017, Volume 2017, Issue 2, p. CD003543
Background Antibiotic resistance is a major public health problem. Infections caused by multidrug-resistant bacteria are associated with prolonged hospital... 
Bacterial | Bacterial Infections [drug therapy; prevention & control] | CLOSTRIDIUM-DIFFICILE INFECTION | COMMUNITY-ACQUIRED PNEUMONIA | Physicians | Humans | ANTIMICROBIAL STEWARDSHIP PROGRAM | RANDOMIZED CONTROLLED-TRIAL | RESISTANT STAPHYLOCOCCUS-AUREUS | INTERRUPTED TIME-SERIES | Practice Patterns | Randomized Controlled Trials as Topic | DECISION-SUPPORT-SYSTEM | Inpatients | MEDICINE, GENERAL & INTERNAL | INTENSIVE-CARE-UNIT | PROCALCITONIN-BASED GUIDELINES | Cross Infection [drug therapy; prevention & control] | Drug Resistance | Anti-Bacterial Agents [adverse effects; therapeutic use] | RESPIRATORY-TRACT INFECTIONS | Bacterial Infections - drug therapy | Cross Infection - prevention & control | Drug Resistance, Bacterial | Practice Patterns, Physicians | Cross Infection - drug therapy | Anti-Bacterial Agents - therapeutic use | Bacterial Infections - prevention & control | Time Factors | Non-Randomized Controlled Trials as Topic | Anti-Bacterial Agents - adverse effects | Anti-Bacterial Agents - administration & dosage
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium difficile Infection
by Debast, S.B and Bauer, M.P and Kuijper, E.J and Comm and European Society of Clinical Microbiology and Infectious Diseases
Clinical Microbiology and Infection, ISSN 1198-743X, 03/2014, Volume 20, Issue 2, pp. 1 - 26
In 2009 the first European Society of Clinical Microbiology and Infection (ESCMID) treatment guidance document for infection (CDI) was published. The guideline... 
treatment | Clostridium difficile infection | recommendations | review | guideline | Recommendations | Guideline | Treatment | Review | PSEUDOMEMBRANOUS COLITIS | INFECTIOUS DISEASES | FECAL MICROBIOTA | ORAL VANCOMYCIN | MICROBIOLOGY | VANCOMYCIN-RESISTANT ENTEROCOCCI | RANDOMIZED CONTROLLED-TRIAL | INTRAVENOUS IMMUNOGLOBULIN | DOUBLE-BLIND | ANTIBIOTIC-ASSOCIATED COLITIS | PLACEBO-CONTROLLED TRIAL | ANTIBODY-RESPONSE | Clostridium Infections - microbiology | Diarrhea - microbiology | Enterocolitis, Pseudomembranous - drug therapy | Humans | Clostridium Infections - drug therapy | Diarrhea - drug therapy | Enterocolitis, Pseudomembranous - microbiology | Clostridium difficile - isolation & purification | Microbiology | Health aspects | Antibacterial agents | Immunotherapy | Trade and professional associations | Ostomy | Infections | Society | Antibiotics | Drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis
by Baur, David, MD and Gladstone, Beryl Primrose, PhD and Burkert, Francesco, MD and Carrara, Elena, MD and Foschi, Federico, MD and Döbele, Stefanie, MD and Tacconelli, Evelina, Prof
Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 9, pp. 990 - 1001
Summary Background Antibiotic stewardship programmes have been shown to reduce antibiotic use and hospital costs. We aimed to evaluate evidence of the effect... 
Infectious Disease | ANTIMICROBIAL STEWARDSHIP | RATES | INFECTIOUS DISEASES | IMPACT | INTENSIVE-CARE-UNIT | USAGE | ACQUISITION | IMPLEMENTATION | ECONOMIC OUTCOMES | DECREASES | PROGRAM | Bacterial Infections - drug therapy | Cross Infection - prevention & control | Gram-Negative Bacteria | Humans | Drug Resistance, Bacterial | Practice Patterns, Physicians | Clostridium Infections - epidemiology | Clostridium difficile - isolation & purification | Clostridium Infections - prevention & control | Cross Infection - drug therapy | Incidence | Methicillin-Resistant Staphylococcus aureus | Anti-Bacterial Agents - therapeutic use | Bacterial Infections - prevention & control | beta-Lactamases | Clostridium Infections - drug therapy | Cross Infection - epidemiology | Medical research | Drug resistance in microorganisms | Analysis | Long-term care of the sick | Medicine, Experimental | Bacteria | Health aspects | Antibacterial agents | Medical care, Cost of | Intervention | Clinical trials | Systematic review | Long term health care | Infections | Vancomycin | Drug resistance | Clinical outcomes | Methicillin | Literature reviews | Heterogeneity | Audits | E coli | Antibiotic resistance | Aminoglycoside antibiotics | Gram-negative bacteria | Bacterial infections | Hospital costs | Staphylococcus infections | Long-term care | Meta-analysis | Studies | Antibiotics | Hygiene | Colonization
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection
by Cammarota, G and Masucci, L and Ianiro, G and Bibbò, S and Dinoi, G and Costamagna, G and Sanguinetti, M and Gasbarrini, A
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 05/2015, Volume 41, Issue 9, pp. 835 - 843
Summary Background Faecal microbiota transplantation (FMT) from healthy donors is considered an effective treatment against recurrent Clostridium difficile... 
FIDAXOMICIN | THERAPY | PREDICTORS | GUIDELINES | DISEASE | PREVENTION | FROZEN INOCULUM | RISK | PHARMACOLOGY & PHARMACY | METRONIDAZOLE | GASTROENTEROLOGY & HEPATOLOGY | Enterocolitis, Pseudomembranous - therapy | Humans | Middle Aged | Male | Treatment Outcome | Clostridium difficile - isolation & purification | Colonoscopy - methods | Feces - microbiology | Enterocolitis, Pseudomembranous - drug therapy | Microbiota | Vancomycin - therapeutic use | Aged, 80 and over | Adult | Clostridium Infections - drug therapy | Female | Aged | Diarrhea - drug therapy | Clostridium Infections - therapy | Relapse | Microbiota (Symbiotic organisms) | Colonoscopy | Clinical trials | Colitis | Vancomycin | Health aspects | Diseases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Fidaxomicin versus Vancomycin for Clostridium difficile Infection
by Louie, Thomas J and Miller, Mark A and Mullane, Kathleen M and Weiss, Karl and Lentnek, Arnold and Golan, Yoav and Gorbach, Sherwood and Sears, Pamela and Shue, Youe-Kong and OPT-80-003 Clinical Study Grp and OPT-80-003 Clinical Study Group
The New England Journal of Medicine, ISSN 0028-4793, 02/2011, Volume 364, Issue 5, pp. 422 - 431
In this randomized trial of fidaxomicin as compared with vancomycin in 629 patients, oral fidaxomicin was shown to be noninferior to oral vancomycin in the... 
UNITED-STATES | MORTALITY | MEDICINE, GENERAL & INTERNAL | RESTRICTION-ENDONUCLEASE ANALYSIS | DIARRHEA | COLITIS | IN-VITRO ACTIVITIES | DISEASE | METRONIDAZOLE | MOLECULAR ANALYSIS | OPT-80 | Clostridium difficile - classification | Prospective Studies | Humans | Middle Aged | Male | Secondary Prevention | Clostridium difficile - isolation & purification | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Feces - microbiology | Adult | Female | Anti-Bacterial Agents - adverse effects | Aminoglycosides - pharmacokinetics | Double-Blind Method | Treatment Outcome | Vancomycin - adverse effects | Enterocolitis, Pseudomembranous - drug therapy | Vancomycin - pharmacokinetics | Vancomycin - therapeutic use | Anti-Bacterial Agents - pharmacokinetics | Intention to Treat Analysis | Clostridium Infections - drug therapy | Aged | Aminoglycosides - adverse effects | Clostridium difficile - drug effects | Aminoglycosides - therapeutic use | Vancomycin | Antibiotics | Clostridium infections | Comparative analysis | Drug therapy | Health aspects | Clinical trials | Infections | Manuscripts | Pharmaceuticals
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Alternatives to antibiotics—a pipeline portfolio review
by Czaplewski, Lloyd, Dr and Bax, Richard, MD and Clokie, Martha, Prof and Dawson, Mike, PhD and Fairhead, Heather, PhD and Fischetti, Vincent A, Prof and Foster, Simon, Prof and Gilmore, Brendan F, Prof and Hancock, Robert E W, Prof and Harper, David, PhD and Henderson, Ian R, Prof and Hilpert, Kai, PhD and Jones, Brian V, PhD and Kadioglu, Aras, Prof and Knowles, David, PhD and Ólafsdóttir, Sigríður, PhD and Payne, David, PhD and Projan, Steve, PhD and Shaunak, Sunil, Prof and Silverman, Jared, PhD and Thomas, Christopher M, Prof and Trust, Trevor J, PhD and Warn, Peter, PhD and Rex, John H, MD
Lancet Infectious Diseases, The, ISSN 1473-3099, 2016, Volume 16, Issue 2, pp. 239 - 251
Summary Antibiotics have saved countless lives and enabled the development of modern medicine over the past 70 years. However, it is clear that the success of... 
Infectious Disease | CALCIUM-EDTA | INFECTIOUS DISEASES | STREPTOCOCCUS-PNEUMONIAE | METALLO-BETA-LACTAMASE | PSEUDOMONAS-AERUGINOSA | BACTERIOPHAGE THERAPY | COMBINATION THERAPY | ESCHERICHIA-COLI | PRESERVES COLONIZATION RESISTANCE | ANTIMICROBIAL PEPTIDES | CLOSTRIDIUM-DIFFICILE | Anti-Bacterial Agents - therapeutic use | Bacterial Infections - prevention & control | Bacterial Infections - drug therapy | Humans | Bacteria - drug effects | Drugs, Investigational - therapeutic use | Drug Resistance, Bacterial - drug effects | Vaccines - therapeutic use | Bacterial infections | Antibiotics | Therapeutics | Homeopathy | Materia medica and therapeutics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Principles of judicious antibiotic prescribing for upper respiratory tract infections in pediatrics
by Hersh, Adam L and Jackson, Mary Anne and Hicks, Lauri A and COMM INFECT DIS and American Academy of Pediatrics Committee on Infectious Diseases and the COMMITTEE ON INFECTIOUS DISEASES
Pediatrics, ISSN 0031-4005, 12/2013, Volume 132, Issue 6, pp. 1146 - 1154
Most upper respiratory tract infections are caused by viruses and require no antibiotics. This clinical report focuses on antibiotic prescribing strategies for... 
Respiratory tract infections | Antibacterial agents | CLOSTRIDIUM-DIFFICILE INFECTION | EMERGENCY-DEPARTMENT VISITS | ADVERSE DRUG EVENTS | HEMOLYTIC STREPTOCOCCAL PHARYNGITIS | ACUTE BACTERIAL SINUSITIS | respiratory tract infections | PNEUMOCOCCAL CONJUGATE VACCINE | antibacterial agents | ACUTE OTITIS-MEDIA | CLINICAL-PRACTICE GUIDELINE | DOUBLE-BLIND | PEDIATRICS | PLACEBO-CONTROLLED TRIAL | Pharyngitis - microbiology | Acute Disease | Sinusitis - diagnosis | Humans | Inappropriate Prescribing - prevention & control | Otitis Media - drug therapy | Contraindications | Pharyngitis - diagnosis | Anti-Bacterial Agents - therapeutic use | Streptococcal Infections - diagnosis | Otitis Media - microbiology | Otitis Media - diagnosis | Pediatrics - methods | Sinusitis - microbiology | Pharyngitis - drug therapy | Streptococcal Infections - drug therapy | Pediatrics - standards | Child | Sinusitis - drug therapy | Pediatrics | Antibiotics | Drug therapy | Prescriptions | Respiratory diseases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights